| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1801 | 2019 |
| Suppressive and gut-reparative functions of human type 1 T regulatory cells L Cook, M Stahl, X Han, A Nazli, KN MacDonald, MQ Wong, K Tsai, ... Gastroenterology 157 (6), 1584-1598, 2019 | 96 | 2019 |
| Methods to manufacture regulatory T cells for cell therapy KN MacDonald, JM Piret, MK Levings Clinical & Experimental Immunology 197 (1), 52-63, 2019 | 94 | 2019 |
| Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions RE Hoeppli, KN MacDonald, P Leclair, VCW Fung, M Mojibian, J Gillies, ... American journal of transplantation 19 (1), 62-76, 2019 | 68 | 2019 |
| Mapping cellular-scale internal mechanics in 3D tissues with thermally responsive hydrogel probes S Mok, S Al Habyan, C Ledoux, W Lee, KN MacDonald, L McCaffrey, ... Nature communications 11 (1), 4757, 2020 | 48 | 2020 |
| Innate control of tissue-reparative human regulatory T cells AJ Lam, KN MacDonald, AM Pesenacker, SC Juvet, KA Morishita, ... The Journal of Immunology 202 (8), 2195-2209, 2019 | 44 | 2019 |
| Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol KN MacDonald, S Ivison, KL Hippen, RE Hoeppli, M Hall, G Zheng, ... Cytotherapy 21 (12), 1216-1233, 2019 | 26 | 2019 |
| Cross talk between human regulatory T cells and antigen‐presenting cells: Lessons for clinical applications CM Wardell, KN MacDonald, MK Levings, L Cook European journal of immunology 51 (1), 27-38, 2021 | 23 | 2021 |
| Manufacturing next-generation regulatory T-cell therapies KN MacDonald, K Salim, MK Levings Current opinion in biotechnology 78, 102822, 2022 | 12 | 2022 |
| The effect of simvastatin treatment on endothelial cell response to shear stress and tumor necrosis factor alpha stimulation M Dick, K MacDonald, JC Tardif, RL Leask Biomedical engineering online 14, 1-12, 2015 | 10 | 2015 |
| Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells KN MacDonald, MG Hall, S Ivison, S Gandhi, RIK Geltink, JM Piret, ... Cytotherapy 24 (11), 1121-1135, 2022 | 7 | 2022 |
| Modelling graft-versus-host disease in mice using human peripheral blood mononuclear cells M Haque, DA Boardman, AJ Lam, KN MacDonald, L Sanderink, Q Huang, ... Bio Protoc 12 (23), e4566, 2022 | 5 | 2022 |
| CD56brightCD16-natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease MP Lauener, S AzadPour, S Abdossamadi, V Parthasarathy, B Ng, ... Haematologica 108 (3), 761, 2023 | 4 | 2023 |
| Process Development and Manufacturing: CELL THERAPY MANUFACTURING PROCESS ANALYTICAL UTILITY OF RAMAN SPECTROSCOPY J Piret, HG Schulze, S Rangan, M Vardaki, KN MacDonald, D Iworima, ... Cytotherapy 25 (6), S199, 2023 | 2 | 2023 |
| Mapping cellular-scale internal stiffness in 3D tissues with smart material hydrogel probes S Mok, S Al Habyan, C Ledoux, W Lee, K MacDonald, L McCaffrey, ... bioRxiv, 840736, 2019 | 1 | 2019 |
| Development of GMP-Compatible Protocols for Thymus-Derived Regulatory T Cell Expansion K MacDonald, R Hoeppli, J Piret, E Dijke, L West, M Levings Transplantation 101 (5S-3), S9, 2017 | 1 | 2017 |
| THYMUS-DERIVED REGULATORY T CELLS AS A UNIVERSAL OFF-THE-SHELF ANTI-INFLAMMATORY THERAPY: TECHNOLOGY TRANSFER IN PREPARATION FOR A PHASE I CLINICAL TRIAL S Ivison, K MacDonald, L Sanderink, M Leung, M Mojibian, JQ Huang, ... Cytotherapy 26 (6), S172-S173, 2024 | | 2024 |
| PROCESS ANALYTICAL UTILITY OF RAMAN SPECTROSCOPY FOR THERAPEUTIC T-CELL MANUFACTURING S Rangan, S Colombini, M Huynh, M Vardaki, HG Schulze, ... Cytotherapy 26 (6), S190-S191, 2024 | | 2024 |
| Immunotherapy: HUMAN CHIMERIC ANTIGEN RECEPTOR REGULATORY T CELLS PREFERENTIALLY MIGRATE TO TUMORS EXPRESSING COGNATE ANTIGEN AS ASSESSED BY CLINICALLY APPLICABLE FLUORINE-19 MRI C Fink, OC Sehl, KN MacDonald, J Kelly, JD Dikeakos, J Ronald, ... Cytotherapy 25 (6), S223-S224, 2023 | | 2023 |
| NKreg Cells Associated with Lack of cGvHD Can Be Identified as a CD56brightCD16- Immunosuppressive Cell Population. MP Lauener, KR Schultz, A Kariminia, S Abdossamadi, S AzadPour, B Ng, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
